Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

The Role of Lectin as Potential Biomarker in Ovarian Cancer

Author(s): Sangita Devi Oinam, Sunil Sing Senjam*, Rana Kamei and Joykishan Sharma Hanjabam

Volume 23, Issue 4, 2022

Published on: 25 June, 2021

Page: [478 - 485] Pages: 8

DOI: 10.2174/1389201022666210625125506

Price: $65

Abstract

Abstract: Lectin acts as an effective tool for screening potential biomarkers and gives an indication of highly valued research. Lectin offers the advantage of having the ability to recognize carbohydrate moiety of glycoprotein, peptidoglycan, glycosides, glycopeptides, lipopolysaccharide etc. makes powerful aid in detecting new cancer biomarkers in most complex tissues and fluids. The unique specificity of lectin in detecting single out anomalously expressed glycosylation pave lectin-based method that can often go down the line for future cancer biomarkers. This article explores the different types of lectin, their sources and possible application in masking the activity of ovarian cancer cells.

Keywords: Lectin, ovarian cancer, biomarker, glycosylation, tumors, glycosylated mucin antigen, N-acetyl galactosamine.

« Previous Next »
[1]
Devi, O.S.; Singh, S.S.; Rana, K.; Sharma, H.J. Different aspects and potential applications of Amphibian Lectins in modern biology: Functional tableau. Asian J. Biochem. Pharm Res., 2019, 9
[2]
Hashim, O.H.; Jayapalan, J.J.; Lee, C.S. Lectins: An effective tool for screening of potential cancer biomarkers. PeerJ, 2017, 5 ,e3784
[http://dx.doi.org/10.7717/peerj.3784] [PMID: 28894650]
[3]
Sharma, H.J.; Devi, K.M.; Devi, W.A. Advanced combinatorial radioimmunogenetic therapy for cancer; Insights Biomed, 2017.
[4]
Lis, H.; Sharon, N. Lectins as molecules and as tools. Annu. Rev. Biochem., 1986, 55, 35-67.
[http://dx.doi.org/10.1146/annurev.bi.55.070186.000343] [PMID: 3527046]
[5]
Peumans, W.J.; Van Damme, E.J.M.; Barre, A.; Rougé, P. Classification of plant lectins in families of structurally and evolutionary related proteins. Adv. Exp. Med. Biol., 2001, 491, 27-54.
[http://dx.doi.org/10.1007/978-1-4615-1267-7_3] [PMID: 14533788]
[6]
Füzéry, A.K.; Levin, J.; Chan, M.M.; Chan, D.W. Translation of proteomic biomarkers into FDA approved cancer diagnostics: Issues and challenges. Clin. Proteomics, 2013, 10(1), 13.
[http://dx.doi.org/10.1186/1559-0275-10-13] [PMID: 24088261]
[7]
Henry, N.L.; Hayes, D.F. Cancer biomarkers. Mol. Oncol., 2012, 6(2), 140-146.
[http://dx.doi.org/10.1016/j.molonc.2012.01.010] [PMID: 22356776]
[8]
Syed, P.; Gidwani, K.; Kekki, H.; Leivo, J.; Pettersson, K.; Lamminmäki, U. Role of lectin microarrays in cancer diagnosis. Proteomics, 2016, 16(8), 1257-1265.
[http://dx.doi.org/10.1002/pmic.201500404] [PMID: 26841254]
[9]
Mesiano, S.; Ferrara, N.; Jaffe, R.B. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization. Am. J. Pathol., 1998, 153(4), 1249-1256.
[http://dx.doi.org/10.1016/S0002-9440(10)65669-6] [PMID: 9777956]
[10]
Ohtsubo, K.; Marth, J.D. Glycosylation in cellular mechanisms of health and disease. Cell, 2006, 126(5), 855-867.
[http://dx.doi.org/10.1016/j.cell.2006.08.019] [PMID: 16959566]
[11]
Magalhães, A.; Duarte, H.O.; Reis, C.A. Aberrant glycosylation in cancer: A novel molecular mechanism controlling metastasis. Cancer Cell, 2017, 31(6), 733-735.
[http://dx.doi.org/10.1016/j.ccell.2017.05.012] [PMID: 28609653]
[12]
Hincapie, M.; Plavina, T.; Hancock, W.S. Sample Preparation in Biological Mass Spectrometry. Sample Prep. Biol. Mass Spectrom., 2011, 515-534.
[13]
Fukushima, K.; Satoh, T.; Baba, S.; Yamashita, K. α1,2-Fucosylated and β-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology, 2010, 20(4), 452-460.
[http://dx.doi.org/10.1093/glycob/cwp197] [PMID: 20008118]
[14]
Avichezer, D.; Arnon, R. Differential reactivities of the Arachis hypogaea (peanut) and Vicia villosa B4 lectins with human ovarian carcinoma cells, grown either in vitro or in vivo xenograft model. FEBS Lett., 1996, 395(2-3), 103-108.
[http://dx.doi.org/10.1016/0014-5793(96)01010-1] [PMID: 8898074]
[15]
Avichezer, D.; Springer, G.F.; Schechter, B.; Arnon, R. Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model. Int. J. Cancer, 1997, 72(1), 119-127.
[http://dx.doi.org/10.1002/(SICI)1097-0215(19970703)72:1<119:AID-IJC17>3.0.CO;2-E] [PMID: 9212232]
[16]
Devine, P.L.; McGuckin, M.A.; Quin, R.J.; Ward, B.G. Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancer. Int. J. Gynecol. Cancer, 1995, 5(3), 170-178.
[http://dx.doi.org/10.1046/j.1525-1438.1995.05030170.x] [PMID: 11578473]
[17]
McGuckin, M.A.; Layton, G.T.; Bailey, M.J.; Hurst, T.; Khoo, S.K.; Ward, B.G. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma comparison with CA125. Gynecol. Oncol., 1990, 37(2), 165-171.
[http://dx.doi.org/10.1016/0090-8258(90)90328-I] [PMID: 1693126]
[18]
Devine, P.L.; McGuckin, M.A.; Ward, B.G. Circulating mucins as tumor markers in ovarian cancer 1992, 12(3), 709-717.
[19]
Swahn, M.L.; Bygdeman, M.; Cekan, S.; Xing, S.; Masironi, B.; Johannisson, E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum. Reprod., 1990, 5(4), 402-408.
[http://dx.doi.org/10.1093/oxfordjournals.humrep.a137111] [PMID: 2113927]
[20]
McGuckin, M.A.; Ramm, L.E.; Joy, G.J.; Free, K.E.; Ward, B.C. Preoperative discrimination between ovarian carcinoma, non-ovarian gynecological malignancy and benign adnexal masses using serum levels of CA125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA. Int. J. Gynecol. Cancer, 1992, 2(3), 119-128.
[http://dx.doi.org/10.1046/j.1525-1438.1992.02030119.x] [PMID: 11576246]
[21]
Mohamed, E. Proteomics analysis of sera of women with normal pregnancy , hydatidiform mole and cancers using lectin- and gel-based approaches. 2013.http://studentsrepo.um.edu.my
[22]
Meyer, T.; Rustin, G.J.S. Role of tumour markers in monitoring epithelial ovarian cancer. Br. J. Cancer, 2000, 82(9), 1535-1538.
[PMID: 10789720]
[23]
Devine, P.L.; McGuckin, M.A.; Ramm, L.E.; Harada, H.; Ward, B.G. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer. Cancer Biochem. Biophys., 1993, 13(4), 221-238.
[PMID: 8521372]
[24]
Hurteau, J.A.; Woolas, R.P.; Jacobs, I.J.; Oram, D.C.; Kurman, C.C.; Rubin, L.A.; Nelson, D.L.; Berchuck, A.; Bast, R.C., Jr; Mills, G.B. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Cancer, 1995, 76(9), 1615-1620.
[http://dx.doi.org/10.1002/1097-0142(19951101)76:9<1615:AID-CNCR2820760918>3.0.CO;2-G] [PMID: 8635066]
[25]
Verri, E.; Guglielmini, P.; Puntoni, M.; Perdelli, L.; Papadia, A.; Lorenzi, P.; Rubagotti, A.; Ragni, N.; Boccardo, F. HER2/neu oncoprotein overexpression in epithelial ovarian cancer: Evaluation of its prevalence and prognostic significance. Clinical study. Oncology, 2005, 68(2-3), 154-161.
[http://dx.doi.org/10.1159/000086958] [PMID: 16020953]
[26]
Lee, C.S. Development of a lectin binding assay for mucin-type-O glycosylated serum proteins:Identification of potential biomarkers for screening of breast cencer. 2017.http://studentsrepo.um.edu.my
[27]
Kozak, K.R.; Su, F.; Whitelegge, J.P.; Faull, K.; Reddy, S.; Farias-Eisner, R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics, 2005, 5(17), 4589-4596.
[http://dx.doi.org/10.1002/pmic.200500093] [PMID: 16237736]
[28]
Kosanović, M.M.; Janković, M.M. Sialylation and fucosylation of cancer-associated prostate specific antigen. J. BUON, 2005, 10(2), 247-250.
[PMID: 17343337]
[29]
Miettinen, M.; Holthofer, H.; Lehto, V.P.; Miettinen, A.; Virtanen, I. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am. J. Clin. Pathol., 1983, 79(1), 32-36.
[http://dx.doi.org/10.1093/ajcp/79.1.32] [PMID: 6401381]
[30]
Meier, B.; Schirmacher, P.; Klesper, B. Expression of lectin binding sites as a prognostic parameter in mouth mucosa carcinomas. Mund Kiefer Gesichtschir., 2001, 5(2), 130-135.
[http://dx.doi.org/10.1007/s100060000267] [PMID: 11372179]
[31]
Stubbs, H.J.; Lih, J.J.; Gustafson, T.L.; Rice, K.G. Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry, 1996, 35(3), 937-947.
[http://dx.doi.org/10.1021/bi9513719] [PMID: 8547276]
[32]
Wu, A.M.; Wu, J.H.; Shen, F. Interaction of a novel Tn (GalNAc α 1-->Ser/Thr) glycoprotein with Gal, GalNAc and GlcNAc specific lectins. Biochem. Biophys. Res. Commun., 1994, 198(1), 251-256.
[http://dx.doi.org/10.1006/bbrc.1994.1035] [PMID: 8292029]
[33]
van der Burg, M.E.L.; Lammes, F.B.; Verweij, J. CA 125 in ovarian cancer. Neth. J. Med., 1992, 40(1-2), 36-51.
[PMID: 1579185]
[34]
Nimmagadda, S.; Penet, M.F. Ovarian cancer targeted theranostics. Front. Oncol., 2020, 9, 1537.
[http://dx.doi.org/10.3389/fonc.2019.01537] [PMID: 32039018]
[35]
Mohamed, E.; Abdul-Rahman, P.S.; Doustjalali, S.R.; Chen, Y.; Lim, B.K.; Omar, S.Z.; Bustam, A.Z.; Singh, V.A.; Mohd-Taib, N.A.; Yip, C.H.; Hashim, O.H. Lectin-based electrophoretic analysis of the expression of the 35 kDa inter-α-trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. Electrophoresis, 2008, 29(12), 2645-2650.
[http://dx.doi.org/10.1002/elps.200700828] [PMID: 18494030]
[36]
Medizin, zur E.; Des, G.; Eines, D. Glycoconjugates as prognostic markers in ovarian cancer. Aus dem Inst. für Anat. II Exp. Morphol., 2005, 34, 434-456.
[37]
Augustin, H.G.; Braun, K.; Telemenakis, I.; Modlich, U.; Kuhn, W. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am. J. Pathol., 1995, 147(2), 339-351.
[PMID: 7543733]
[38]
Lin, T.C.; Chen, S.T.; Huang, M.C.; Huang, J.; Hsu, C.L.; Juan, H.F.; Lin, H.H.; Chen, C.H. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Oncotarget, 2017, 8(26), 42588-42601.
[http://dx.doi.org/10.18632/oncotarget.16585] [PMID: 28388560]
[39]
Tatsuta, T.; Hosono, M.; Takahashi, K.; Omoto, T.; Kariya, Y.; Sugawara, S.; Hakomori, S.; Nitta, K. Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL. Int. J. Oncol., 2014, 44(2), 377-384.
[http://dx.doi.org/10.3892/ijo.2013.2192] [PMID: 24297392]
[40]
Christie, D.R.; Shaikh, F.M.; Lucas, J.A., IV; Lucas, J.A., III; Bellis, S.L. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J. Ovarian Res., 2008, 1(1), 3.
[http://dx.doi.org/10.1186/1757-2215-1-3] [PMID: 19014651]
[41]
Amin, A.R.M.R.; Paul, R.K.; Thakur, V.S.; Agarwal, M.L. A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin. Concanavalin A. Cancer Res., 2007, 67(12), 5617-5621.
[http://dx.doi.org/10.1158/0008-5472.CAN-07-0655] [PMID: 17575126]
[42]
Liu, B.; Cheng, Y.; Zhang, B.; Bian, H.J.; Bao, J.K. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway. Cancer Lett., 2009, 275(1), 54-60.
[http://dx.doi.org/10.1016/j.canlet.2008.09.042] [PMID: 19010591]
[43]
Peng, H.; Lv, H.; Wang, Y.; Liu, Y.H.; Li, C.Y.; Meng, L.; Chen, F.; Bao, J.K. Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities. Peptides, 2009, 30(10), 1805-1815.
[http://dx.doi.org/10.1016/j.peptides.2009.06.027] [PMID: 19577602]
[44]
Saha, S.H.M.; Tuhin, N.; Jahan, A.R.; Roy, P. Antibacterial and antioxidant activities of a food lectin isolated from the seeds of lablab purpureous. Am. J Ethnomed, 2014, 1(1), 008-017.
[45]
Dias, Rde. O. Machado, Ldos.S.; Migliolo, L.; Franco, O.L. Insights into animal and plant lectins with antimicrobial activities. Molecules, 2015, 20(1), 519-541.
[http://dx.doi.org/10.3390/molecules20010519] [PMID: 25569512]
[46]
Klafke, G.B.; Moreira, G.M.S.G.; Monte, L.G.; Pereira, J.L.; Brandolt, T.M.; Xavier, M.O.; Santi-Gadelha, T.; Dellagostin, O.A.; Pinto, L.S. Assessment of plant lectin antifungal potential against yeasts of major importance in medical mycology. Mycopathologia, 2012.
[http://dx.doi.org/10.1007/s11046-012-9596-x] [PMID: 23161017]
[47]
Regente, M.; Taveira, G.B.; Pinedo, M.; Elizalde, M.M.; Ticchi, A.J.; Diz, M.S.S.; Carvalho, A.O.; de la Canal, L.; Gomes, V.M. A sunflower lectin with antifungal properties and putative medical mycology applications. Curr. Microbiol., 2014, 69(1), 88-95.
[http://dx.doi.org/10.1007/s00284-014-0558-z] [PMID: 24623187]
[48]
Tobata-Kudo, H.; Kudo, H.; Tada, I. Strongyloides ratti: chemokinesis of glycolytic enzyme- and lectin-treated third-stage infective larvae in vitro. Parasitol. Int., 2005, 54(2), 147-152.
[http://dx.doi.org/10.1016/j.parint.2005.03.001] [PMID: 15866477]
[49]
Heim, C.; Hertzberg, H.; Butschi, A.; Bleuler-Martinez, S.; Aebi, M.; Deplazes, P.; Künzler, M.; Štefanić, S. Inhibition of Haemonchus contortus larval development by fungal lectins. Parasit. Vectors, 2015, 8, 425.
[http://dx.doi.org/10.1186/s13071-015-1032-x] [PMID: 26283415]
[50]
Lusvarghi, S.; Bewley, C.A. Griffithsin: An antiviral lectin with outstanding therapeutic potential. Viruses, 2016, 8(10), 296.
[http://dx.doi.org/10.3390/v8100296] [PMID: 27783038]
[51]
Clark, D.; Mao, L. Cancer biomarker discovery: Lectin-based strategies targeting glycoproteins. Dis. Markers, 2012, 33(1), 1-10.
[http://dx.doi.org/10.1155/2012/308738] [PMID: 22710864]
[52]
Singh, R.S.; Bhari, R.; Rana, V.; Tiwary, A.K. Immunomodulatory and therapeutic potential of a mycelial lectin from Aspergillus nidulans. Appl. Biochem. Biotechnol., 2011, 165(2), 624-638.
[http://dx.doi.org/10.1007/s12010-011-9281-4] [PMID: 21590306]
[53]
Ditamo, Y.; Rupil, L.L.; Sendra, V.G.; Nores, G.A.; Roth, G.A.; Irazoqui, F.J. In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus. Food Funct., 2016, 7(1), 262-269.
[http://dx.doi.org/10.1039/C5FO00360A] [PMID: 26399519]
[54]
Silva, M.C.; de Paula, C.A.; Ferreira, J.G.; Paredes-Gamero, E.J.; Vaz, A.M.; Sampaio, M.U.; Correia, M.T.; Oliva, M.L. Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cells. Biochim. Biophys. Acta, 2014, 1840(7), 2262-2271.
[http://dx.doi.org/10.1016/j.bbagen.2014.03.009] [PMID: 24641823]
[55]
Quiroga, A.V.; Barrio, D.A.; Añón, M.C. Amaranth lectin presents potential antitumor properties. Lebensm. Wiss. Technol., 2015, 60, 478-485.
[http://dx.doi.org/10.1016/j.lwt.2014.07.035]
[56]
Jebali, J.; Fakhfekh, E.; Morgen, M.; Srairi-Abid, N.; Majdoub, H.; Gargouri, A.; El Ayeb, M.; Luis, J.; Marrakchi, N.; Sarray, S. Lebecin, a new C-type lectin like protein from Macrovipera lebetina venom with anti-tumor activity against the breast cancer cell line MDA-MB231. Toxicon, 2014, 86, 16-27.
[http://dx.doi.org/10.1016/j.toxicon.2014.04.010] [PMID: 24814013]
[57]
Brustein, V.P.; Souza-Araújo, F.V.; Vaz, A.F.M.; Araújo, R.V.S.; Paiva, P.M.G.; Coelho, L.C.B.B.; Carneiro-Leão, A.M.A.; Teixeira, J.A.; Carneiro-da-Cunha, M.G.; Correia, M.T.S. A novel antimicrobial lectin from Eugenia malaccensis that stimulates cutaneous healing in mice model. Inflammopharmacology, 2012, 20(6), 315-322.
[http://dx.doi.org/10.1007/s10787-011-0113-5] [PMID: 22271003]
[58]
Coriolano, M.C.; de Melo, C.M. Silva, Fde.O.; Schirato, G.V.; Porto, C.S.; dos Santos, P.J.; Correia, M.T.; Porto, A.L.; Carneiro-Leão, A.M.; Coelho, L.C. Parkia pendula seed lectin: Potential use to treat cutaneous wounds in healthy and immunocompromised mice. Appl. Biochem. Biotechnol., 2014, 172(5), 2682-2693.
[http://dx.doi.org/10.1007/s12010-013-0692-2] [PMID: 24425299]

Rights & Permissions Print Cite
Article Metrics
27
1
© 2024 Bentham Science Publishers | Privacy Policy